MedTrace Logo

Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia

NCT04569487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-07-31

No results posted yet for this study

Summary

The objective of this trial is to constitute a cohort of sarcopenic versus non-sarcopenic patients to validate the most relevant biological, imaging, mobility and clinical markers considered individually or in association for the diagnosis of sarcopenic patients.

Conditions

Interventions

PROCEDURE

Biopsy

Muscle biopsy from vastus lateralis (100-200 mg from non-dominant leg)

Sponsors & Collaborators

  • Artialis

    lead INDUSTRY

Principal Investigators

  • Yves Henrotin, Prof · Artialis

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2024-04-02
Completion
2024-04-02

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04569487 on ClinicalTrials.gov